These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Lipoatrophy after insulin injections can be treated with lipofilling]. Lund PS; Sjøstrand H; Matzen SH Ugeskr Laeger; 2016 Dec; 178(49):. PubMed ID: 27959262 [TBL] [Abstract][Full Text] [Related]
5. [Insulin lipoatrophy and its elimination through the use of monocomponent insulin]. Maaz E Z Gesamte Inn Med; 1976 Nov; 31(22):941-5. PubMed ID: 1035452 [TBL] [Abstract][Full Text] [Related]
7. Distant site lipoatrophy: a rare complication of subcutaneous insulin therapy. Chakraborty PP; Biswas SN Postgrad Med J; 2016 Jan; 92(1083):57-8. PubMed ID: 26561591 [No Abstract] [Full Text] [Related]
8. [Lipodystrophia following insulin injection]. Mehnert H Med Klin; 1972 Oct; 67(42):1384. PubMed ID: 4640226 [No Abstract] [Full Text] [Related]
9. Use of dexamethasone in treatment of insulin lipoatrophy. Kumar O; Miller L; Mehtalia S Diabetes; 1977 Apr; 26(4):296-9. PubMed ID: 849810 [TBL] [Abstract][Full Text] [Related]
10. Treatment of insulin lipoatrophy with monocomponent insulin. Teuscher A Diabetologia; 1974 Jun; 10(3):211-4. PubMed ID: 4845721 [No Abstract] [Full Text] [Related]
11. Lipoatrophy associated with rapid-acting insulin analogues in young patients with type 1 diabetes mellitus. Szypowska A; Skórka A; Pańkowska E Pediatr Endocrinol Diabetes Metab; 2008; 14(2):117-8. PubMed ID: 18721499 [TBL] [Abstract][Full Text] [Related]
12. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Richardson T; Kerr D Am J Clin Dermatol; 2003; 4(10):661-7. PubMed ID: 14507228 [TBL] [Abstract][Full Text] [Related]
13. Insulin-induced Lipoatrophy in a Patient on Insulin Analogue Therapy: a Case Report. Yanachkova V; Staynova R Folia Med (Plovdiv); 2020 Sep; 62(3):597-600. PubMed ID: 33009748 [TBL] [Abstract][Full Text] [Related]
14. A case of lipoatrophy with insulin detemir. Del Olmo MI; Campos V; Abellán P; Merino-Torres JF; Piñón F Diabetes Res Clin Pract; 2008 Apr; 80(1):e20-1. PubMed ID: 18281121 [TBL] [Abstract][Full Text] [Related]
15. Pan-insulin allergy and severe lipoatrophy complicating Type 2 diabetes. Tavare AN; Doolittle HJ; Baburaj R Diabet Med; 2011 Apr; 28(4):500-3. PubMed ID: 21392071 [TBL] [Abstract][Full Text] [Related]
16. Continuous subcutaneous insulin infusion (CSII) in the management of diabetic lipodystrophy: a case report. Cimino A; Valentini U; Rotondi A; Radaeli E; Giustina G Acta Diabetol Lat; 1987; 24(2):165-7. PubMed ID: 3307259 [TBL] [Abstract][Full Text] [Related]
17. Injection site lipoatrophy: a rare complication of recombinant human insulin. Chakraborty PP; Bhattacharjee R J Assoc Physicians India; 2010 Oct; 58():630. PubMed ID: 21510114 [No Abstract] [Full Text] [Related]
18. Insulin-induced lipoatrophy: evidence for an immune pathogenesis. Reeves WG; Allen BR; Tattersall RB Br Med J; 1980 Jun; 280(6230):1500-3. PubMed ID: 6992934 [TBL] [Abstract][Full Text] [Related]